The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis

被引:30
|
作者
Papadimitrakopoulou, Vassiliki A.
Brown, Erika N.
Liu, Diane D.
El-Naggar, Adel K.
Lee, J. Jack
Hong, Waun Ki
Lee, Ho-Young
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, THNMO Unit 432, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
关键词
head and neck cancer; insulin-like growth factor binding protein 3;
D O I
10.1016/j.canlet.2005.08.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The activities of insulin-like growth factors (IGFs) in regulating cell proliferation, differentiation, and apoptosis are modulated by a family of high-affinity specific IGF-binding proteins (IGFBPs), IGFBP-3 being the most abundant in circulation. Down-regulation of IGFBP-3 has been shown to be associated with a shorter disease-specific survival probability in early non-small-cell lung cancer (NSCLC). We examined the prognostic role of IGFBP-3 protein expression loss in 34 squamous cell carcinomas (SCC) of the tongue (stages II-IV) and 30 premalignant lesions of the oral cavity and the larynx. Reduced IGFBP-3 expression was found in 11 (32%) of 34 tongue SCC cases, and was associated with significantly shorter disease-specific and disease-free survival (P=0.0002 and < 0.0001 by Log-rank test). In premalignant lesions, IGFBP3 loss was found in 8 (27%) of 30 cases without significant association with cancer-free survival. Therefore, down-regulation of IGFBP-3 is an early event during head and neck carcinogenesis, that bears an adverse prognostic significance in tongue cancer and could serve as both a marker of aggressive disease and target for intervention. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:136 / 143
页数:8
相关论文
共 50 条
  • [1] Transferrin is an insulin-like growth factor-binding protein-3 binding protein
    Weinzimer, SA
    Gibson, TB
    Collett-Solberg, PF
    Khare, A
    Liu, BR
    Cohen, P
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04): : 1806 - 1813
  • [2] EXPRESSION OF HUMAN INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3 IN TRANSGENIC MICE
    MURPHY, LJ
    MOLNAR, P
    LU, X
    HUANG, H
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1995, 15 (03) : 293 - 303
  • [3] GLUCOCORTICOID REGULATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3
    VILLAFUERTE, BC
    KOOP, BL
    PAO, CI
    PHILLIPS, LS
    ENDOCRINOLOGY, 1995, 136 (05) : 1928 - 1933
  • [4] Adenoviral-mediated expression of human insulin-like growth factor-binding protein-3
    Firth, SM
    Ganeshprasad, U
    Poronnik, P
    Cook, DI
    Baxter, RC
    PROTEIN EXPRESSION AND PURIFICATION, 1999, 16 (01) : 202 - 211
  • [5] Bovine lactoferrin binds to insulin-like growth factor-binding protein-3
    Baumrucker, CR
    Gibson, CA
    Schanbacher, FL
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2003, 24 (04) : 287 - 303
  • [6] Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3
    Chan, Sophie S. Y.
    Schedlich, Lynette J.
    Twigg, Stephen M.
    Baxter, Robert C.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 296 (04): : E654 - E663
  • [7] Insulin-like growth factor-binding protein-3 binds fibrinogen and fibrin
    Campbell, PG
    Durham, SK
    Hayes, JD
    Suwanichkul, A
    Powell, DR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) : 30215 - 30221
  • [8] USE OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3 FOR THE EVALUATION OF GROWTH DISORDERS
    BLUM, WF
    RANKE, MB
    HORMONE RESEARCH, 1990, 33 : 31 - 37
  • [9] Insulin-like growth factor-binding protein-3 and breast cancer survival
    Yu, H
    Levesque, MA
    Khosravi, MJ
    Papanastasiou-Diamandi, A
    Clark, GM
    Diamandis, EP
    INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (06) : 624 - 628
  • [10] Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction
    Iglesias, P
    Bayón, C
    Méndez, J
    Gancedo, PG
    Grande, C
    Díez, JJ
    THYROID, 2001, 11 (11) : 1043 - 1048